(Q40879555)

24 September 2017

Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation (English)

1 reference

24 September 2017

0 references

1 reference

Kadowaki S

1

1 reference

24 September 2017

Chen Z

2

1 reference

24 September 2017

Asanuma H

3

1 reference

24 September 2017

Aizawa C

4

1 reference

24 September 2017

Kurata T

5

1 reference

24 September 2017

Tamura S

6

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

24 September 2017

1 reference

24 September 2017

18

1 reference

24 September 2017

25

1 reference

24 September 2017

2779-2788

1 reference

describes a project that uses

24 September 2017

1 reference

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Gene vaccination: plasmid DNA is more than just a blueprint

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Gene transfer into muscle by electroporation in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Mucosal immunization with DNA encoding influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Immunization with purified N1 and N2 influenza virus neuraminidases demonstrates cross-reactivity without antigenic competition

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Efficient selection for high-expression transfectants with a novel eukaryotic vector

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Plaque assay and primary isolation of influenza a viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Immunogenicity and efficacy of DNA vaccines encoding influenza A proteins in aged mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

The recovery of mice from influenza A virus infection: adoptive transfer of immunity with influenza virus-specific cytotoxic T lymphocytes recognizing a common virion antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

Electroporation therapy: a new approach for the treatment of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900087-6

7 January 2021

10.1016/S0264-410X(00)00087-6

Identifiers

DOI

1 reference

release_c7r2tbe4bngjpczg4g2fcsxuj4

24 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/c7r2tbe4bngjpczg4g2fcsxuj4

24 November 2022

mapped directly with Wikidata item

1 reference